Comparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis

BACKGROUND: Basiliximab and anti‐thymocyte globulin are widely used drugs for induction therapy after pediatric heart transplantation. The aim of this study was to determine whether any differences could be observed between basiliximab and anti‐thymocyte globulin, with respect to long‐term mortality...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, David, Höglund, Peter, Andersson, Bodil, Nilsson, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859398/
https://www.ncbi.nlm.nih.gov/pubmed/26722127
http://dx.doi.org/10.1161/JAHA.115.002790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859398/
https://www.ncbi.nlm.nih.gov/pubmed/26722127
http://dx.doi.org/10.1161/JAHA.115.002790

Ejemplares similares